Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any colorectal cancer in which the cause of the disease is a mutation in the GALNT12 gene.
Biomarker and diagnostic research for colorectal cancer, susceptibility to, 1 has been reported in the published literature.
No clinical trials have been registered for colorectal cancer, susceptibility to, 1.
298 publications have been identified in PubMed for colorectal cancer, susceptibility to, 1. Research spans Epidemiology / Natural History (38%), Basic Science / Preclinical (30%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 112 | 38% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:52 AM UTC
Online Mendelian Inheritance in Man
Common questions about colorectal cancer, susceptibility to, 1
Laboratory research
88 |
30% |
Research summaries | 51 | 17% |
Testing and diagnosis research | 23 | 8% |
New treatment approaches | 12 | 4% |
Clinical study results | 8 | 3% |
Patient case studies | 4 | 1% |
Helfand BT (2026). [PMID: 42053416](https://pubmed.ncbi.nlm.nih.gov/42053416/). *Prostate*. [Epidemiology / Natural History]
Yu HP (2026). [PMID: 41241147](https://pubmed.ncbi.nlm.nih.gov/41241147/). *J Genet Genomics*. [Epidemiology / Natural History]
Dalamaga M (2026). [PMID: 41857189](https://pubmed.ncbi.nlm.nih.gov/41857189/). *Curr Obes Rep*. [Review / Meta-Analysis]
Wang W (2026). [PMID: 41361120](https://pubmed.ncbi.nlm.nih.gov/41361120/). *Arch Toxicol*. [Review / Meta-Analysis]
Greuter MJE (2026). [PMID: 42133209](https://pubmed.ncbi.nlm.nih.gov/42133209/). *Fam Cancer*. [Epidemiology / Natural History]
Maccaroni E (2026). [PMID: 41809563](https://pubmed.ncbi.nlm.nih.gov/41809563/). *Hum Mutat*. [Clinical Trial Publication]
Ding H (2026). [PMID: 41833930](https://pubmed.ncbi.nlm.nih.gov/41833930/). *Nat Commun*. [Basic Science / Preclinical]
Glykofridis IE (2026). [PMID: 41543911](https://pubmed.ncbi.nlm.nih.gov/41543911/). *Proc Natl Acad Sci U S A*. [Diagnostic / Biomarker]
Nagaraja S (2026). [PMID: 41882356](https://pubmed.ncbi.nlm.nih.gov/41882356/). *Nature*. [Basic Science / Preclinical]
Zhang A (2026). [PMID: 42144703](https://pubmed.ncbi.nlm.nih.gov/42144703/). *Cancer Med*. [Epidemiology / Natural History]